TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35029612 — Predictive Biomarker (PRD): MUC2 mRNA
Genes: MUC2; SMUC
Study 32210365 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 32210365 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 32545038 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32545038 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33184328 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 33184328 — Surrogate Endpoint (SUR): Blood pressure
Study 35038699 — Surrogate Endpoint (SUR): Blood pressure
Study 33511817 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 35307068 — Monitoring Biomarker (MOI): Procalcitonin
Study 35307068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35307068 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35307068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34986027 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34986027 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 32430457 — Surrogate Endpoint (SUR): Blood pressure
Study 33683083 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32482645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32933119 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 32833845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34494090 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33284129 — Surrogate Endpoint (SUR): Blood pressure
Study 35769481 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 35769481 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 35905798 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33167109 — Surrogate Endpoint (SUR): Blood pressure
Study 35720011 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 35720011 — Surrogate Endpoint (SUR): Blood pressure
Study 32938496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32938496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32938496 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33356728 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 35472008 — Predictive Biomarker (PRD): Liver iron
Study 34494323 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 35468621 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 35468621 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 35468621 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34936264 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34936264 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 34936264 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34936264 — Safety Biomarker (SAF): BDNF
Study 34658904 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 34658904 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34658904 — Predictive Biomarker (PRD): HEY1 mRNA
Genes: HEY1; BHLHB31; CHF2; HERP2; HESR1; HRT1
Study 35552107 — Surrogate Endpoint (SUR): Blood pressure
Study 32347934 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 32851713 — Surrogate Endpoint (SUR): Serum creatinine
Study 32898170 — Predictive Biomarker (PRD): MAVS mRNA
Genes: MAVS; IPS1; KIAA1271; VISA
Study 34217654 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 32246050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34305584 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 33030304 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 35170783 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35170783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34598676 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34373282 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 34106974 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33400348 — Surrogate Endpoint (SUR): Serum uric acid
Study 33400348 — Surrogate Endpoint (SUR): Blood pressure
Study 616172822 — Surrogate Endpoint (SUR): Blood pressure
Study 32538291 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 32538291 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 32538291 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 32538291 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 32538291 — Predictive Biomarker (PRD): SLC22A1 mRNA
Genes: SLC22A1; OCT1
Study 35016403 — Surrogate Endpoint (SUR): Blood pressure
Study 35296534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35466343 — Surrogate Endpoint (SUR): Blood pressure
Study 33008287 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34108673 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33356422 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33356422 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33243018 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33243018 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 35766224 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 33774620 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 32318809 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 36227659 — Safety Biomarker (SAF): Hyaluronic acid
Study 33779577 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 36096108 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36096108 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35762272 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 32124728 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35631319 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33551282 — Surrogate Endpoint (SUR): Blood pressure
Study 34682668 — Surrogate Endpoint (SUR): Bone mineral density
Study 34115544 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34115544 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study 33753870 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34103434 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34743666 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34662180 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 34187482 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study 34734262 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34734262 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32823413 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32823413 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34016732 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35057479 — Surrogate Endpoint (SUR): Blood pressure
Study 32013936 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 36163982 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 35512402 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35512402 — Predictive Biomarker (PRD): Hormone receptor
Study 35837711 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35226723 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33128206 — Monitoring Biomarker (MOI): HBV DNA
Study 34933219 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study 33198514 — Surrogate Endpoint (SUR): Blood pressure
Study 35899310 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34097448 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32639235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34843069 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34843069 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33713484 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 36034207 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study 35534868 — Surrogate Endpoint (SUR): Blood pressure
Study 33909857 — Surrogate Endpoint (SUR): Blood pressure
Study 36085061 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 36085061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36085061 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 34606574 — Surrogate Endpoint (SUR): Blood pressure
Study 34547486 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35947305 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32854838 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32854838 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33112433 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 33112433 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 32067256 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33919779 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 33607805 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32762224 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32762224 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34280733 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35594122 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 36123113 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 33380165 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 32339648 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32115517 — Surrogate Endpoint (SUR): Serum uric acid
Study 32862264 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33632022 — Surrogate Endpoint (SUR): Blood pressure
Study 33530854 — Surrogate Endpoint (SUR): Blood pressure
Study 33530854 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33843376 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33843376 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 33316626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33623999 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32007823 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32007823 — Surrogate Endpoint (SUR): Blood pressure
Study 35905507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 32517785 — Surrogate Endpoint (SUR): Blood pressure
Study 34116351 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32513518 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34802955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34802955 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34802955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32629706 — Surrogate Endpoint (SUR): Blood pressure
Study 36355434 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 34431029 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 34067585 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34067585 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 34067585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34067585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34067585 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34067585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33140457 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 35049373 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 32729244 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33070053 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33070053 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35473740 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33540340 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 34286397 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 34286397 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34286397 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34286397 — Surrogate Endpoint (SUR): Serum creatinine
Study 34286397 — Surrogate Endpoint (SUR): Serum triglycerides
Study 34297067 — Surrogate Endpoint (SUR): Bone mineral density
Study 34404427 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study 34404427 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 36117055 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 33023684 — Surrogate Endpoint (SUR): Blood pressure
Study 33299898 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32324435 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 32324435 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32324435 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34971795 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34971795 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32304015 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32304015 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 35817957 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 32333541 — Predictive Biomarker (PRD): ST7 mRNA
Genes: ST7; FAM4A1; HELG; RAY1
Study 32333541 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34883037 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 32912276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33164956 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 33164956 — Surrogate Endpoint (SUR): Forced vital capacity
Study 37286262 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 32541548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32541548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35749144 — Surrogate Endpoint (SUR): Blood pressure
Study 32332617 — Surrogate Endpoint (SUR): Blood pressure
Study 35773633 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35773633 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35773633 — Safety Biomarker (SAF): BDNF
Study 35773633 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33764445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33768619 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35798534 — Safety Biomarker (SAF): Interleukin 12
Study 36041126 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34335840 — Surrogate Endpoint (SUR): Blood pressure
Study 34385543 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32684486 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34061883 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 33538417 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 32074419 — Surrogate Endpoint (SUR): Blood pressure
Study 33979838 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34051124 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33751636 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 34230150 — Predictive Biomarker (PRD): ITFG1 mRNA
Genes: ITFG1; LNKN-1; TIP; CDA08
Study 33694196 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 35770629 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35770629 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32450869 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36143879 — Surrogate Endpoint (SUR): Blood pressure
Study 33080005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32847020 — Surrogate Endpoint (SUR): Bone mineral density
Study 33841399 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33526633 — Surrogate Endpoint (SUR): Blood pressure
Study 35493500 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34259423 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 35304048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34086101 — Surrogate Endpoint (SUR): Bone mineral density
Study 32548624 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study 34526250 — Surrogate Endpoint (SUR): Bone mineral density
Study 33590901 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32315461 — Predictive Biomarker (PRD): DBI mRNA
Genes: DBI
Study 32844557 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34287900 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 34125503 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34125503 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 34630155 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 34247582 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 33974170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33974170 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35095084 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 36283254 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGA mRNA
Genes: FGA
Study 34542654 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32034016 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32138790 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32138790 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32957816 — Predictive Biomarker (PRD): HEATR5A mRNA
Genes: HEATR5A; C14orf125; KIAA1316
Study 32957816 — Predictive Biomarker (PRD): PRRC2B mRNA
Genes: PRRC2B; BAT2L; BAT2L1; KIAA0515
Study 32957816 — Predictive Biomarker (PRD): RBM25 mRNA
Genes: RBM25; RNPC7
Study 32957816 — Predictive Biomarker (PRD): ZC3H13 mRNA
Genes: ZC3H13; KIAA0853
Study 32957816 — Predictive Biomarker (PRD): LRRK1 mRNA
Genes: LRRK1; KIAA1790
Study 32741773 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 33711262 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32129141 — Safety Biomarker (SAF): Hyaluronic acid
Study 33832352 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35511258 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35272940 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 35241246 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34648948 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33727409 — Surrogate Endpoint (SUR): Blood pressure
Study 32851636 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 35037057 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 33164259 — Surrogate Endpoint (SUR): Blood pressure
Study 35397122 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA